Clobazam’s most frequently reported side effects are drowsiness, sedation, and dizziness, followed by unsteadiness and lethargy. Compared with older benzodiazepines, clobazam tends to produce less severe sedation and less psychomotor impairment, which is a large part of why it became a go-to add-on therapy for seizure disorders. But the drug is not free of problems, and some of its side effects, particularly behavioral changes in children and amplified toxicity in people with certain genetic profiles, catch patients and caregivers off guard.
The Most Common Side Effects
Across roughly fifty epilepsy clinical trials in adults and children, the side effects that showed up most consistently were drowsiness, sedation, dizziness, and ataxia (a loss of coordination that can make walking feel unsteady).1PubMed. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam In the pivotal trial for Lennox-Gastaut syndrome, which led to FDA approval in the United States, the most frequent adverse events were somnolence, fever, upper respiratory infections, and lethargy.2PubMed Central. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome A large pharmacovigilance analysis of real-world adverse event reports confirmed somnolence as the most common non-seizure-related complaint, and flagged drug interactions as a surprisingly frequent problem as well.3PubMed. Safety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports
A study focused specifically on children with epilepsy found side effects in about 30% of patients. The most common were insomnia, agitation, and somnolence. Allergic reactions were the rarest, and the study reported no cases of ataxia, blood pressure changes, or constipation in its pediatric group.4The European Research Journal. The side effects of clobazam as add-on therapy in pediatric epilepsy patients That picture is worth noting because insomnia and agitation are almost the opposite of what you would expect from a sedating drug, and they hint at the behavioral side effects that deserve their own discussion.
Why Clobazam Is Less Sedating Than Other Benzodiazepines
Clobazam was deliberately designed to be different. It belongs to a chemical subclass called 1,5-benzodiazepines, while most familiar drugs in this family, like diazepam and clonazepam, are 1,4-benzodiazepines. The structural tweak was intended to preserve the anticonvulsant and anti-anxiety benefits while reducing the heaviness and brain fog that come with older benzodiazepines.5PubMed. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam That goal appears to have been partly achieved. Early reviews found that while patients on clobazam reported subjective drowsiness at rates similar to diazepam, objective measures of psychomotor performance told a different story: clobazam caused less measurable impairment.6PubMed. Clobazam: a review of its pharmacological properties and therapeutic use in anxiety
Head-to-head comparisons with clonazepam, another benzodiazepine commonly used in epilepsy, reinforced the pattern. In one study of healthy volunteers, clobazam at both 10 mg and 20 mg produced significantly fewer psychomotor side effects than clonazepam at 0.5 mg and 1 mg, with neither drug affecting breathing responses at those doses.7PubMed Central. Respiratory and sedative effects of clobazam and clonazepam in volunteers Several studies of people with anxiety also found that clobazam actually enhanced performance on cognitive tests, which is unusual for any benzodiazepine.8PubMed. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam So if you or your child has been prescribed clobazam after struggling with sedation on another benzodiazepine, the switch is grounded in real evidence. But “less sedating” is not the same as “non-sedating.” Drowsiness remains the single most common complaint.
Behavioral and Psychiatric Side Effects
This is where clobazam can blindside families. Aggression, agitation, and self-injurious behavior are recognized side effects, and they crop up more often in children. In one study of 63 children with hard-to-treat epilepsy, about 11% developed a severe behavioral disorder after starting clobazam. The pattern included aggressive agitation, self-injury, insomnia, and nonstop motor activity, and it appeared anywhere from 10 to 55 days after starting the drug.9PubMed. Aggression in children treated with clobazam for epilepsy
A larger analysis specifically examined aggression-related events in children with Lennox-Gastaut syndrome taking clobazam. Roughly 14% of treated patients experienced some kind of aggression-related event. An interesting finding from that analysis was that a child’s prior history of aggression did not meaningfully increase the likelihood: about 17% of those with a history experienced an event, compared with about 16% of those without one.10PubMed. Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut Syndrome In other words, these behavioral changes can appear in children with no prior tendency toward aggression, making it harder to predict who is at risk.
If you are a parent or caregiver, the practical point is clear: monitor behavior closely in the first two months after starting clobazam. The onset window in published reports stretches from about a week and a half to nearly two months. Any sudden shift toward irritability, sleeplessness, or unusual combativeness warrants a prompt conversation with the prescribing physician.
Cognitive Effects Over Time
Parents and patients often worry that a benzodiazepine taken daily for epilepsy will slowly erode memory or thinking ability. The evidence here is somewhat reassuring. A study that compared children on clobazam monotherapy to children on standard epilepsy monotherapy (carbamazepine or valproate) found no differences on any neuropsychological measure at either 6 weeks or 12 months. Children who stayed on clobazam for the full year showed no deterioration in cognitive performance.11PubMed. The cognitive and behavioural effects of clobazam and standard monotherapy are comparable That does not rule out subtle effects in every individual, and the picture in older adults may differ (more on that below), but it is a meaningful data point for parents weighing the tradeoffs.
Drug Interactions That Amplify Side Effects
A substantial share of clobazam’s real-world problems are not caused by clobazam alone but by the way it interacts with other medications. In the large pharmacovigilance database analysis mentioned earlier, drug interactions ranked as the third most frequently reported signal after seizures and somnolence.12PubMed. Safety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports Because most people taking clobazam are already on other seizure medications, these interactions are almost unavoidable in practice.
A few specific interactions stand out:
- Valproic acid: Clobazam slows the clearance of valproic acid, potentially pushing valproate blood levels high enough to cause its own toxicity. Monitoring valproate blood levels after adding clobazam is recommended.13PubMed. Interactions of clobazam with conventional antiepileptics in children
- Stiripentol: When stiripentol is given alongside clobazam, levels of clobazam’s main active metabolite (called N-desmethylclobazam, or norclobazam) can jump by five to eight times their usual concentration. Higher norclobazam levels are directly linked to a greater probability of somnolence.14PubMed. Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures
- Lamotrigine and valproic acid together: A case report described a 7-year-old boy who developed Stevens-Johnson syndrome, a rare and potentially life-threatening skin reaction, four weeks after clobazam was added to an existing regimen of lamotrigine and valproic acid. The treating physicians attributed the reaction to a three-way drug interaction.15PubMed Central. Stevens-Johnson Syndrome triggered by a combination of clobazam, lamotrigine and valproic acid in a 7-year-old child
Cannabidiol (CBD), which is increasingly used as an add-on for refractory epilepsy, also inhibits the enzyme that breaks down norclobazam, and can push sedation levels higher. If your regimen includes both CBD and clobazam, the prescriber may need to reduce the clobazam dose.
Genetic Metabolism and the CYP2C19 Factor
Clobazam is metabolized in the liver to norclobazam, which is itself pharmacologically active, meaning it contributes to both the therapeutic effect and the side effects. Norclobazam is then cleared by an enzyme called CYP2C19. Some people carry gene variants that make this enzyme sluggish or completely inactive; they are known as poor metabolizers. In those individuals, norclobazam concentrations can reach levels roughly seven times higher than in people with normal enzyme activity, while the parent drug concentration rises only modestly, by about 30 to 50%.16PubMed Central. PharmGKB summary: clobazam pathway, pharmacokinetics
The consequences can be severe. A published case report describes an adult patient who became comatose on a standard therapeutic dose of clobazam. Genetic testing revealed he was a CYP2C19 poor metabolizer, and his norclobazam levels were dramatically elevated.17PubMed Central. Elevations in Norclobazam Concentrations and Altered Mental Status in CYP2C19 Poor Metabolizer Phenotype: A Case Report This is not a theoretical concern. The poor metabolizer phenotype is more common in certain populations, affecting roughly 2 to 3% of people of European descent and up to 15 to 20% of people of East Asian descent. Pharmacogenomic testing before or shortly after starting clobazam can identify patients at risk, and the FDA-approved labeling recommends dose adjustment for poor metabolizers.
If you experience disproportionate drowsiness, confusion, or coordination problems on what your doctor considers a normal dose, CYP2C19 testing is a reasonable thing to ask about. It is a straightforward genetic test available through most reference labs.
Fall Risk in Older Adults
For elderly patients, sedation is not just an inconvenience; it is a direct fall risk. Research on psychotropic drugs and postural control has consistently found that these medications impair balance, and the effect grows worse with higher doses, longer half-lives, and older age.18PubMed. The effects of fall-risk-increasing drugs on postural control: a literature review
Clobazam specifically has been linked to a higher fall rate among older adults. In a cross-sectional study of a community-dwelling elderly population, clobazam use was associated with a roughly 2.5-fold increase in the number of falls after adjusting for age, sex, and other variables. That association was statistically significant and remained so even after the adjustments, making clobazam one of the benzodiazepines most strongly tied to recurrent falls in that study.19PubMed Central. Association between benzodiazepines and recurrent falls: a cross-sectional elderly population-based study For an older adult with epilepsy or another condition that warrants a benzodiazepine, this tradeoff has to be weighed carefully. Falls in the elderly can lead to hip fractures and head injuries that carry their own serious mortality risk. Starting at the lowest effective dose and reassessing regularly matters more in this age group than in any other.
Tolerance and Whether the Drug Stops Working
One of the persistent concerns with any benzodiazepine used long-term for seizure control is tolerance: the gradual loss of effectiveness as the body adapts. This happens through changes at the receptor level, where the brain’s targets for the drug become less responsive over time. Tolerance can reduce side effects (the drowsiness many people experience early on often fades), but it can also reduce the drug’s ability to control seizures. This process is reversible after stopping the medication.20PubMed Central. Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy Clinicians sometimes manage this by using clobazam intermittently rather than continuously, for instance cycling it on and off or reserving it for periods of seizure worsening, though this approach is more art than science.
Withdrawal and How to Stop Safely
Stopping clobazam abruptly can provoke withdrawal symptoms, a risk shared by all benzodiazepines. Withdrawal reactions from clobazam have been documented for decades.21PubMed Central. Withdrawal reaction from clobazam The good news is that these reactions can usually be avoided with a gradual taper. Data from clinical trials of clobazam in Lennox-Gastaut syndrome showed that a 2-to-3-week tapering schedule, which is actually faster than what most clinicians would use in practice, was enough to prevent withdrawal-related events in the patients who discontinued during the trials.22Epilepsy & Behavior. Withdrawal-related adverse events from clinical trials of clobazam in Lennox–Gastaut syndrome
In clinical practice, tapering typically happens over several weeks and sometimes longer, depending on how long the patient has been taking the drug and how high the dose has been. The main risks of stopping too quickly include rebound seizures, anxiety, insomnia, and irritability. If you are considering discontinuing clobazam, always do so under medical guidance rather than stopping on your own.
Pregnancy Concerns
Evidence on clobazam’s safety during pregnancy is limited, but what exists raises caution. A meta-analysis examining gestational exposure to clobazam found signals pointing to an increased risk of major congenital malformations in infants of women with epilepsy who used the drug during pregnancy. The associations did not reach statistical significance in every analysis, and the risk was not elevated in polytherapy contexts, making interpretation complicated. Still, the signal was consistent enough across datasets from multiple countries that the authors concluded there appears to be an increased risk.23PubMed. Gestational Exposure to Benzodiazepines, 3: Clobazam and Major Congenital Malformations For women of childbearing age who are taking clobazam, this is a conversation to have with a neurologist well before pregnancy, not after it begins. Switching to a medication with a more established safety profile in pregnancy may be possible, though it depends entirely on how well the current regimen controls seizures.
The Rare But Serious Skin Reaction
Stevens-Johnson syndrome and its more severe variant, toxic epidermal necrolysis, are rare but potentially fatal skin reactions that have been reported with clobazam. The earlier-mentioned case in a child taking a combination of clobazam, lamotrigine, and valproic acid involved a generalized rash, fever, and liver and kidney involvement.24PubMed Central. Stevens-Johnson Syndrome triggered by a combination of clobazam, lamotrigine and valproic acid in a 7-year-old child In that case, the interplay between multiple drugs was considered the trigger, making it hard to pin the blame on clobazam alone. Lamotrigine is itself well known for this risk. The practical lesson is to watch for any unexplained rash or skin blistering after starting clobazam, especially when it is added to a regimen that already includes lamotrigine. Prompt medical attention and drug discontinuation are critical if such a reaction develops.
What Makes Clobazam Side Effects Unpredictable in Some People
A recurring theme in the evidence is that clobazam’s side-effect profile varies widely from person to person, and several factors converge to make it hard to predict who will tolerate it well. Genetic CYP2C19 status creates a sevenfold difference in the blood levels of the drug’s main active metabolite.25PubMed Central. PharmGKB summary: clobazam pathway, pharmacokinetics The number and identity of other medications in the regimen can further amplify or mask the effects. Age plays a role, with older adults more susceptible to sedation and falls and children more prone to behavioral activation. And the underlying neurological condition itself can produce symptoms that overlap with drug side effects, making attribution tricky. Seizure worsening, for instance, topped the adverse-event reports in the real-world pharmacovigilance analysis, and sorting out whether that reflects the disease progressing or the drug causing harm requires careful clinical judgment.26PubMed. Safety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports
None of this makes clobazam a particularly dangerous drug by the standards of seizure medications, which as a class tend to have substantial side-effect profiles. The evidence across trials consistently positions clobazam as less sedating and less cognitively impairing than other benzodiazepines used in epilepsy.27PubMed Central. Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy But the variability is real, and the side effects that do occur can range from mild drowsiness to coma in an extreme case. Starting at a low dose, checking drug interactions carefully, considering genetic testing if the response seems off, and watching for behavioral changes in the first couple of months cover most of the avoidable ground.